Welcome To 4th Microbiome Movement - Drug Development Summit

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

Part of the foremost conference series for microbiome researchers in industry, the 4th Microbiome Movement – Drug Development Europe 2020 returns to unite leading scientists from the biopharmaceutical and academic community to pursue the causal role of the microbiome in disease, and help create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes.

Across three days of case-studies, discussion and debates, learn how industry and academic leaders are understanding microbiome functionality across key therapeutic modalities, leveraging big data platforms to deduce causality, and overcoming regulatory, clinical and manufacturing hurdles to further accelerate their pipeline across new disease targets.

At this critical time, and as the microbiome community waits for the first clinical breakthrough,  join your peers and unlock the potential of the human microbiome to create the next generation of microbiome-based therapeutics and diagnostic candidates of the future.

Alex p

Alexander Puttick
Program Director & Co-Founder
Microbiome Movement

Top 3 reasons to attemd-DDE

Top 3 Reasons To Attend

  • Save time and resources by learning how leading companies are overcoming critical translational hurdles to drive microbiome R&D into a therapeutic reality
  • Gain an important market update on the progress of microbiome-based therapeutics to benchmark your progress
  • Establish lasting connections by joining the foremost series of industry conference for microbiome researchers

Hear What Our Customers Say

"As a newcomer to the microbiome field, this conference provided an excellent overview.”

Richard Shanksky
Seres  Therapeutics

“It was a great conference to effectively learn the current trends in microbiome drug development around the world.”

Nanae Izumi
Daiichi Sankyo